Charles Sawyers and colleagues have conducted a small early-stage clinical study to assess target modulation by the small-molecule inhibitor rapamycin. Rapamycin is approved to treat renal cancer ...

But out of all the supplements and drugs he takes for 'living healthy forever', one key medicine that Bryan and other ...